InvestorsHub Logo
Followers 4
Posts 984
Boards Moderated 0
Alias Born 07/27/2011

Re: DewDiligence post# 12366

Wednesday, 08/13/2014 12:47:08 PM

Wednesday, August 13, 2014 12:47:08 PM

Post# of 20689
Dew,

They mention heparin, Enoxaparin and 402 in their patent application. They might just be covering all the bases. LWMH is the key I think.

They sure are going to a lot of trouble if they are not planning on selling a product. They comment on the problems regarding hair loss for chemo patients.

Here are the patent applications. Please take a look. You might then be able to understand if they would then require FDA approval once the patents are approved.

http://worldwide.espacenet.com/publicationDetails/inpadocPatentFamily?CC=EP&NR=2582355A2&KC=A2&FT=D&ND=3&date=20130424&DB=EPODOC&locale=en_EP